Committee Lens Health, Employment, Labor, and Pensions
— committee · oversees Health
Trades by this committee's members in the sector(s) it oversees — the committee's conflict surface — ranked by Conflict Score. How it's scored.
157
Flagged trades
5 / 7
Members trading in-jurisdiction
$2,285,578
Est. disclosed volume
75/100
Worst conflict score
Who's trading in-jurisdiction
| Conflict | Member | Ticker | Company | Type | Date | Amount | Sector | Source |
|---|---|---|---|---|---|---|---|---|
| 75 | Lisa McClain | LLY | Eli Lilly & Co. | BUY | 2024-12-11 | $1K–$15K | Health | ↗ filing |
| 75 | Lisa McClain | ZTS | Zoetis Inc. | BUY | 2024-12-11 | $1K–$15K | Health | ↗ filing |
| 75 | Lisa McClain | VRTX | Vertex Pharmaceuticals Inc. / Ma | BUY | 2024-12-11 | $1K–$15K | Health | ↗ filing |
| 75 | Lisa McClain | ISRG | Intuitive Surgical Inc. | BUY | 2024-12-11 | $1K–$15K | Health | ↗ filing |
| 75 | Lisa McClain | BSX | Boston Scientific Corp. | BUY | 2024-12-11 | $1K–$15K | Health | ↗ filing |
| 75 | Lisa McClain | ZTS | Zoetis Inc. | SELL | 2025-01-15 | $1K–$15K | Health | ↗ filing |
| 71 | Lisa McClain | SNN | Smith & Nephew plc | BUY | 2025-06-09 | $1K–$15K | Health | ↗ filing |
| 71 | Lisa McClain | NVO | Novo Nordisk A S | BUY | 2025-06-09 | $1K–$15K | Health | ↗ filing |
| 71 | Lisa McClain | NVS | Novartis AG | BUY | 2025-06-09 | $1K–$15K | Health | ↗ filing |
| 71 | Lisa McClain | AZN | Astrazeneca plc | BUY | 2025-06-09 | $1K–$15K | Health | ↗ filing |
| 71 | Lisa McClain | LLY | Eli Lilly & Co. | SELL | 2025-06-09 | $1K–$15K | Health | ↗ filing |
| 71 | Lisa McClain | ISRG | Intuitive Surgical Inc. | SELL | 2025-06-09 | $1K–$15K | Health | ↗ filing |
| 70 | Lisa McClain | THC | Tenet Healthcare Corp. | BUY | 2025-06-11 | $1K–$15K | Health | ↗ filing |
| 70 | Lisa McClain | CYTK | Cytokinetics Inc. | BUY | 2025-06-11 | $1K–$15K | Health | ↗ filing |
| 70 | Lisa McClain | VRTX | Vertex Pharmaceuticals Inc. / Ma | SELL | 2025-06-10 | $1K–$15K | Health | ↗ filing |
| 70 | Lisa McClain | NVS | Novartis AG | BUY | 2025-06-11 | $1K–$15K | Health | ↗ filing |
| 70 | Lisa McClain | VRTX | Vertex Pharmaceuticals Inc. / Ma | SELL | 2025-06-11 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | JNJ | Johnson & Johnson | BUY | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | BDX | Becton Dickinson & Co. | BUY | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | ABBV | Abbvie Inc. | BUY | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | SNY | Sanofi | BUY | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | GSK | Gsk plc | BUY | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | SNN | Smith & Nephew plc | SELL | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | CYTK | Cytokinetics Inc. | SELL | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | AZN | Astrazeneca plc | SELL | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 69 | Lisa McClain | NVS | Novartis AG | BUY | 2025-06-17 | $1K–$15K | Health | ↗ filing |
| 68 | Lisa McClain | MRK | Merck & Co. Inc. | BUY | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 68 | Lisa McClain | AMGN | Amgen Inc. | BUY | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 68 | Lisa McClain | ABT | Abbott Laboratories | BUY | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 68 | Virginia Foxx | GSK | Gsk plc | SELL | 2022-07-12 | $100K–$250K | Health | ↗ filing |
| 68 | Lisa McClain | JNJ | Johnson & Johnson | SELL | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 68 | Lisa McClain | GSK | Gsk plc | SELL | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 68 | Lisa McClain | BDX | Becton Dickinson & Co. | SELL | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 65 | Richard Allen | MRK | Merck & Co. Inc. | SELL | 2017-11-30 | $1K–$15K | Health | ↗ filing |
| 65 | Richard Allen | ABBV | Abbvie Inc. | BUY | 2020-05-12 | $15K–$50K | Health | ↗ filing |
| 65 | Richard Allen | ABT | Abbott Laboratories | BUY | 2019-09-13 | $15K–$50K | Health | ↗ filing |
| 65 | Richard Allen | PFE | Pfizer Inc. | SELL | 2023-03-14 | $15K–$50K | Health | ↗ filing |
| 65 | Richard Allen | JNJ | Johnson & Johnson | BUY | 2019-10-02 | $1K–$15K | Health | ↗ filing |
| 65 | Lisa McClain | ABT | Abbott Laboratories | SELL | 2025-07-10 | $1K–$15K | Health | ↗ filing |
| 65 | Lisa McClain | NVO | Novo Nordisk A S | SELL | 2025-07-10 | $1K–$15K | Health | ↗ filing |
| 65 | Lisa McClain | LLY | Eli Lilly & Co. | BUY | 2025-07-10 | $1K–$15K | Health | ↗ filing |
| 65 | Lisa McClain | ISRG | Intuitive Surgical Inc. | BUY | 2025-07-10 | $1K–$15K | Health | ↗ filing |
| 64 | Richard Allen | PFE | Pfizer Inc. | BUY | 2021-07-15 | $15K–$50K | Health | ↗ filing |
| 64 | Lisa McClain | PFE | Pfizer Inc. | BUY | 2025-07-16 | $1K–$15K | Health | ↗ filing |
| 64 | Virginia Foxx | AMGN | Amgen Inc. | BUY | 2024-12-06 | $1K–$15K | Health | ↗ filing |
| 64 | Virginia Foxx | ABBV | Abbvie Inc. | BUY | 2024-12-06 | $1K–$15K | Health | ↗ filing |
| 64 | Virginia Foxx | JNJ | Johnson & Johnson | BUY | 2024-12-06 | $1K–$15K | Health | ↗ filing |
| 64 | Richard Allen | ABBV | Abbvie Inc. | BUY | 2020-11-16 | $15K–$50K | Health | ↗ filing |
| 64 | Richard Allen | AMGN | Amgen Inc. | BUY | 2022-08-18 | $15K–$50K | Health | ↗ filing |
| 64 | Richard Allen | JNJ | Johnson & Johnson | SELL | 2024-07-16 | $15K–$50K | Health | ↗ filing |
| 64 | Lisa McClain | LLY | Eli Lilly & Co. | SELL | 2025-07-16 | $1K–$15K | Health | ↗ filing |
| 64 | Lisa McClain | ISRG | Intuitive Surgical Inc. | SELL | 2025-07-16 | $1K–$15K | Health | ↗ filing |
| 63 | Virginia Foxx | JNJ | Johnson & Johnson | BUY | 2016-11-23 | $50K–$100K | Health | ↗ filing |
| 63 | Virginia Foxx | MRK | Merck & Co. Inc. | SELL | 2014-10-13 | $50K–$100K | Health | ↗ filing |
| 63 | Richard Allen | MMM | 3M Co. | BUY | 2019-06-19 | $15K–$50K | Health | ↗ filing |
| 63 | Virginia Foxx | PFE | Pfizer Inc. | SELL | 2018-02-08 | $50K–$100K | Health | ↗ filing |
| 63 | Lisa McClain | ABBV | Abbvie Inc. | SELL | 2025-07-22 | $1K–$15K | Health | ↗ filing |
| 63 | Lisa McClain | ABBV | Abbvie Inc. | BUY | 2025-07-22 | $1K–$15K | Health | ↗ filing |
| 63 | Lisa McClain | SNY | Sanofi | SELL | 2025-07-22 | $1K–$15K | Health | ↗ filing |
| 63 | Richard Allen | MMM | 3M Co. | SELL | 2020-05-14 | $1K–$15K | Health | ↗ filing |
| 63 | Lisa McClain | ZTS | Zoetis Inc. | BUY | 2025-07-22 | $1K–$15K | Health | ↗ filing |
| 63 | Lisa McClain | AZN | Astrazeneca plc | BUY | 2025-07-22 | $1K–$15K | Health | ↗ filing |
| 63 | Lisa McClain | NVS | Novartis AG | SELL | 2025-07-22 | $1K–$15K | Health | ↗ filing |
| 62 | Richard Allen | MMM | 3M Co. | SELL | 2019-05-17 | $1K–$15K | Health | ↗ filing |
| 62 | Lisa McClain | HCA | Hca Healthcare, Inc. | SELL | 2025-09-11 | $1K–$15K | Health | ↗ filing |
| 62 | Lisa McClain | NVO | Novo Nordisk A S | BUY | 2025-09-11 | $1K–$15K | Health | ↗ filing |
| 62 | Lisa McClain | SNY | Sanofi | SELL | 2025-09-11 | $1K–$15K | Health | ↗ filing |
| 62 | Lisa McClain | NVS | Novartis AG | BUY | 2025-09-11 | $1K–$15K | Health | ↗ filing |
| 59 | Richard Allen | AMGN | Amgen Inc. | BUY | 2019-08-29 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | GSK | Gsk plc | BUY | 2016-02-11 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | PFE | Pfizer Inc. | BUY | 2016-01-20 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | ABT | Abbott Laboratories | BUY | 2015-03-18 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | PFE | Pfizer Inc. | BUY | 2017-08-01 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | JNJ | Johnson & Johnson | BUY | 2021-05-04 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | AMGN | Amgen Inc. | BUY | 2019-09-27 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | GSK | Gsk plc | BUY | 2017-08-04 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | MRK | Merck & Co. Inc. | SELL | 2017-11-21 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | MRK | Merck & Co. Inc. | BUY | 2020-07-02 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | MRK | Merck & Co. Inc. | BUY | 2020-07-02 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | ABT | Abbott Laboratories | BUY | 2019-09-27 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | MRK | Merck & Co. Inc. | BUY | 2017-03-17 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | ABT | Abbott Laboratories | SELL | 2015-08-21 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | MMM | 3M Co. | BUY | 2019-08-22 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | MRK | Merck & Co. Inc. | SELL | 2021-03-10 | $15K–$50K | Health | ↗ filing |
| 59 | Richard Allen | MMM | 3M Co. | SELL | 2020-05-14 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | GSK | Gsk plc | BUY | 2018-12-11 | $15K–$50K | Health | ↗ filing |
| 59 | Virginia Foxx | GSK | Gsk plc | BUY | 2020-04-13 | $15K–$50K | Health | ↗ filing |
| 57 | Michael Rulli | LLY | Eli Lilly & Co. | SELL | 2025-12-02 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | TAK | Takeda Pharmaceutical Co. Ltd. | BUY | 2022-11-01 | $1K–$15K | Health | ↗ filing |
| 57 | Joe Courtney | ZTS | Zoetis Inc. | BUY | 2019-12-31 | $1K–$15K | Health | ↗ filing |
| 57 | Joe Courtney | ABT | Abbott Laboratories | BUY | 2019-12-31 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | HCA | Hca Healthcare, Inc. | BUY | 2025-08-19 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | BMY | Bristol Myers Squibb Co. | SELL | 2025-06-24 | $1K–$15K | Health | ↗ filing |
| 57 | Michael Rulli | PFE | Pfizer Inc. | SELL | 2024-11-26 | $1K–$15K | Health | ↗ filing |
| 57 | Joe Courtney | ZTS | Zoetis Inc. | SELL | 2020-08-07 | $1K–$15K | Health | ↗ filing |
| 57 | Joe Courtney | ABT | Abbott Laboratories | SELL | 2020-08-07 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2017-10-24 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | TAK | Takeda Pharmaceutical Co. Ltd. | BUY | 2023-02-16 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2017-10-25 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | MRK | Merck & Co. Inc. | SELL | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | MRK | Merck & Co. Inc. | BUY | 2017-10-11 | $1K–$15K | Health | ↗ filing |
| 57 | Michael Rulli | LLY | Eli Lilly & Co. | SELL | 2026-07-01 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | PFE | Pfizer Inc. | SELL | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | BSX | Boston Scientific Corp. | SELL | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | ABT | Abbott Laboratories | BUY | 2016-01-22 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2018-04-12 | $1K–$15K | Health | ↗ filing |
| 57 | Michael Rulli | LLY | Eli Lilly & Co. | BUY | 2026-01-02 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | AMGN | Amgen Inc. | SELL | 2025-09-25 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | THC | Tenet Healthcare Corp. | SELL | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | JNJ | Johnson & Johnson | BUY | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | JNJ | Johnson & Johnson | SELL | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Richard Allen | MMM | 3M Co. | SELL | 2020-05-14 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | ABT | Abbott Laboratories | BUY | 2016-01-28 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | BSX | Boston Scientific Corp. | BUY | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | BSX | Boston Scientific Corp. | SELL | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | NVO | Novo Nordisk A S | SELL | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2020-10-09 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | ABT | Abbott Laboratories | SELL | 2016-11-10 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | JNJ | Johnson & Johnson | SELL | 2025-10-31 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2018-10-09 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | AZN | Astrazeneca plc | BUY | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | ABBV | Abbvie Inc. | SELL | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | ZTS | Zoetis Inc. | SELL | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | SNY | Sanofi | BUY | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | JNJ | Johnson & Johnson | BUY | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | GSK | Gsk plc | BUY | 2025-08-04 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2019-01-10 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | BSX | Boston Scientific Corp. | SELL | 2025-10-31 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | NVO | Novo Nordisk A S | BUY | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2019-04-12 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2022-08-16 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2022-08-09 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2022-07-06 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2022-04-08 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2022-02-22 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2022-01-14 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2021-10-08 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2021-07-09 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2021-04-09 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2021-01-15 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2020-07-10 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2020-01-10 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2019-10-11 | $1K–$15K | Health | ↗ filing |
| 57 | Virginia Foxx | GSK | Gsk plc | BUY | 2019-07-12 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | ABBV | Abbvie Inc. | SELL | 2025-10-31 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | GSK | Gsk plc | SELL | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | GSK | Gsk plc | BUY | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | AZN | Astrazeneca plc | SELL | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | ABBV | Abbvie Inc. | BUY | 2025-10-30 | $1K–$15K | Health | ↗ filing |
| 57 | Lisa McClain | NVO | Novo Nordisk A S | SELL | 2025-10-30 | $1K–$15K | Health | ↗ filing |
Showing the top 150 of 157 flagged trades by Conflict Score.